Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment

BACKGROUND: Despite the success of TNF-inhibitor therapy in rheumatoid arthritis treatment, up to 40% of patients fail to respond adequately. This study aimed to identify transcriptome-based biomarkers of adalimumab response in rheumatoid arthritis (RA) to aid timely switching in non-responder patie...

Descripción completa

Detalles Bibliográficos
Autores principales: OIiver, James, Nair, Nisha, Orozco, Gisela, Smith, Samantha, Hyrich, Kimme L., Morgan, Ann, Isaacs, John, Wilson, Anthony G., Barton, Anne, Plant, Darren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948368/
https://www.ncbi.nlm.nih.gov/pubmed/33691749
http://dx.doi.org/10.1186/s13075-021-02451-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948368/
https://www.ncbi.nlm.nih.gov/pubmed/33691749
http://dx.doi.org/10.1186/s13075-021-02451-9

Ejemplares similares